PDCD1 and neoplasm: This occurs because a variety of harmful molecules are released during ablation, including tumor-associated antigens, inflammatory cytokines, etc. In mouse models, we observed that incomplete radiofrequency ablation (iRFA) promotes tumor growth and impedes the efficacy of anti-PD-1 therapy.